UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

POS1030 EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY BASELINE SKIN SEVERITY: A SUBGROUP ANALYSIS OF TWO PHASE III TRIALS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.786-787

2021

Volltextzugriff (PDF)

POS0508 EVALUATION OF RESPONSE TO PNEUMOCOCCAL VACCINATION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB: RESULTS FROM A PHASE 2 OPEN-LABEL EXTENSION STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.486-487

2021

Volltextzugriff (PDF)

FRI0144 Analysis of the Association Between Cigarette Smoking and Clinical Response to Certolizumab Pegol Treatment in Hungarian Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.474-474

2015

Volltextzugriff (PDF)

OP0002 Tofacitinib in Patients with Ankylosing Spondylitis: A Phase 2, 16-Week, Randomised, Placebo-Controlled, Dose-Ranging Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.52-53

2016

Volltextzugriff (PDF)

THU0168 Baricitinib Inhibits Radiographic Progression of Structural Joint Damage at 1 Year in Patients with Rheumatoid Arthritis (RA) and An Inadequate Response To csDMARDs

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.244-245

2016

Volltextzugriff (PDF)

SAT0244 A Phase Iib Study of the Efficacy and Safety of Subcutaneous Clazakizumab (ANTI-IL-6 Monoclonal Antibody) with or without Methotrexate in Adults with Moderate-To-Severe Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.680-681

2014

Volltextzugriff (PDF)

SAT0350 Quality of Life with Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 24 and 48-Week Data from A Randomized, Double-Blind, Placebo-Controlled Trial

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.719-719

2014

Volltextzugriff (PDF)

LB0001 Baricitinib, an Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and An Inadequate Response to CDMARD Therapy: Results of the Phase 3 RA-Build Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.79-79

2015

Volltextzugriff (PDF)

OP0203 Orally-administered CCR1 antagonist CCX354-C in a phase 2 rheumatoid arthritis study

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.123-124

2013

Volltextzugriff (PDF)

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

Annals of the rheumatic diseases, 2014-06, Vol.73 (6), p.990-999

2014

Volltextzugriff (PDF)

POS0307 A PHASE 2 TRIAL OF PERESOLIMAB FOR ADULTS WITH RHEUMATOID ARTHRITIS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.397-397

2023

Volltextzugriff (PDF)

LBA0005 EFFICACY AND SAFETY OF IZOKIBEP, A NOVEL IL-17A INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: WEEK 16 RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2b/3 STUDY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.235-236

2024

Volltextzugriff (PDF)

OP0258 IZOKIBEP (ABY-035) IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS – 16-WEEK RESULTS FROM A PHASE 2 STUDY

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.170-171

2022

Volltextzugriff (PDF)

CD8β/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes

Clinical and experimental immunology, 2003-09, Vol.133 (3), p.334-343

2003

Volltextzugriff (PDF)

Efficacité d’upadacitinib chez des patients atteints de rhumatisme psoriasique stratifiés selon la sévérité de l’atteinte cutanée à l’inclusion : analyse en sous-groupes de deux études de phase III

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A195-A196

2021

Volltextzugriff (PDF)

United University Professions: Pioneering in Higher Education Unionism

SUNY Press, 2019

2019

Volltextzugriff (PDF)

In-situ synthesis of Y2W3O12 within a Co-based superalloy powder mixture

International journal of materials research, 2010-08, Vol.101 (8), p.1042-1045

2010

Volltextzugriff (PDF)

Poly(ADP-ribose) polymerase polymorphisms are not a genetic risk factor for systemic lupus erythematosus in German Caucasians

Journal of rheumatology, 2000-08, Vol.27 (8), p.2061

2000

Volltextzugriff (PDF)

Treating contaminated sediment with a two-stage base-catalyzed decomposition (BCD) process: bench-scale evaluation

Journal of hazardous materials, 1997-10, Vol.56 (3), p.287-306

1997

Volltextzugriff (PDF)

BARICITINIBE VS. PBO E ADALIMUMABE NA ARTRITE REUMATOIDE MOD A GRAVE ‐ RESULTADOS DO RA‐BEAM

Revista Brasileira de reumatologia, 2017, Vol.57, p.S380-S381

2017

Volltextzugriff (PDF)

The princes and princesses of possibilities

The Journal of emergency medicine, 1997, Vol.15 (1), p.101-105

1997

Volltextzugriff (PDF)

Residual stress measurements in welded steel beam column connections by scanning acoustic microscopy

Journal of materials science, 1999-09, Vol.34 (17), p.4173-4179

1999

Volltextzugriff (PDF)

Mapping stress with ultrasound

Nature (London), 1996-11, Vol.384 (6604), p.52-55

1996

Volltextzugriff (PDF)

Novel residual stress measurement techniques to measure residual stresses in fiber reinforced composites

Journal of materials science, 1999-02, Vol.34 (3), p.557-563

1999

Volltextzugriff (PDF)

Leaky axisymmetric modes in infinite clad rods. I

The Journal of the Acoustical Society of America, 1992-08, Vol.92 (2), p.1061-1090

1992

Volltextzugriff (PDF)

1 – 25 von 938

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieZeitschrift Für Physik C Particles And Fields

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(676)
Mit Volltextzugriff
(708)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

POS1030 EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY BASELINE SKIN SEVERITY: A SUBGROUP ANALYSIS OF TWO PHASE III TRIALS

POS0508 EVALUATION OF RESPONSE TO PNEUMOCOCCAL VACCINATION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB: RESULTS FROM A PHASE 2 OPEN-LABEL EXTENSION STUDY

FRI0144 Analysis of the Association Between Cigarette Smoking and Clinical Response to Certolizumab Pegol Treatment in Hungarian Patients with Rheumatoid Arthritis

OP0002 Tofacitinib in Patients with Ankylosing Spondylitis: A Phase 2, 16-Week, Randomised, Placebo-Controlled, Dose-Ranging Study

THU0168 Baricitinib Inhibits Radiographic Progression of Structural Joint Damage at 1 Year in Patients with Rheumatoid Arthritis (RA) and An Inadequate Response To csDMARDs

SAT0244 A Phase Iib Study of the Efficacy and Safety of Subcutaneous Clazakizumab (ANTI-IL-6 Monoclonal Antibody) with or without Methotrexate in Adults with Moderate-To-Severe Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate

SAT0350 Quality of Life with Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 24 and 48-Week Data from A Randomized, Double-Blind, Placebo-Controlled Trial

LB0001 Baricitinib, an Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and An Inadequate Response to CDMARD Therapy: Results of the Phase 3 RA-Build Study

OP0203 Orally-administered CCR1 antagonist CCX354-C in a phase 2 rheumatoid arthritis study

POS0307 A PHASE 2 TRIAL OF PERESOLIMAB FOR ADULTS WITH RHEUMATOID ARTHRITIS

LBA0005 EFFICACY AND SAFETY OF IZOKIBEP, A NOVEL IL-17A INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: WEEK 16 RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2b/3 STUDY

OP0258 IZOKIBEP (ABY-035) IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS – 16-WEEK RESULTS FROM A PHASE 2 STUDY

CD8β/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes

Efficacité d’upadacitinib chez des patients atteints de rhumatisme psoriasique stratifiés selon la sévérité de l’atteinte cutanée à l’inclusion : analyse en sous-groupes de deux études de phase III

United University Professions: Pioneering in Higher Education Unionism

In-situ synthesis of Y2W3O12 within a Co-based superalloy powder mixture

Poly(ADP-ribose) polymerase polymorphisms are not a genetic risk factor for systemic lupus erythematosus in German Caucasians

Treating contaminated sediment with a two-stage base-catalyzed decomposition (BCD) process: bench-scale evaluation

BARICITINIBE VS. PBO E ADALIMUMABE NA ARTRITE REUMATOIDE MOD A GRAVE ‐ RESULTADOS DO RA‐BEAM

The princes and princesses of possibilities

Residual stress measurements in welded steel beam column connections by scanning acoustic microscopy

Mapping stress with ultrasound

Novel residual stress measurement techniques to measure residual stresses in fiber reinforced composites

Leaky axisymmetric modes in infinite clad rods. I

Aktive Filter

Suchergebnisse filtern